amitriptyline has been researched along with Polycystic Ovarian Syndrome in 2 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alkan, I | 1 |
| Kaplan, S | 1 |
| Li, X | 1 |
| Wang, S | 1 |
| Zhang, L | 2 |
| Liu, J | 1 |
| Luo, H | 1 |
| Gou, K | 1 |
| Cui, S | 1 |
2 other studies available for amitriptyline and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
An investigation of the potential effects of amitriptyline on polycystic ovary syndrome induced by estradiol valerate.
Topics: Amitriptyline; Animals; Chloramphenicol O-Acetyltransferase; Estradiol; Female; Follicle Stimulating | 2023 |
Amitriptyline plays important roles in modifying the ovarian morphology and improving its functions in rats with estradiol valerate-induced polycystic ovary.
Topics: Amitriptyline; Animals; Antidepressive Agents; Estradiol; Female; Ovary; Polycystic Ovary Syndrome; | 2019 |